سيرامزا 500 مجم / 50 مل فيال

ramucirumab is a fully human monoclonal antibody (igg1) developed for the treatment of solid tumors. it is directed against the vascular endothelial growth factor receptor 2 (vegfr2). by binding to vegfr2 it works as a receptor antagonist.